| payload |
{"created_at":"2026-04-20T18:43:38.570 {"created_at":"2026-04-20T18:43:38.570177+00:00","signal_type":"news_headline_delta","source":"news_rss","url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQM3cwOTRmS3h5WEFRemsxT1JuYjVLVlJlVE1rYUVxMVpEQlZSWVRaeFBwTnRmMHB3ZnN0SHpFQ0M4QlYyaWJWTTV4ZGZUSndxQi1RYU0tUEZ4YmpoLU5oWEZLSlVoUUZtRTQydnFiSVpTblR5a1VaYUpUOVdtZ1BybEZRSjVhYUhvNmFLZkR2RllhUXdsV0QwdnhLcmpjaWV4Qk9JV2tzVk05MVpVaDM1cWdmNmdhUlJwck8tc2JnVVRlV0hSVkFFVEFfZk1pdw?oc=5","value":{"fp":"95b634fcf6240c82","published_at":"2026-04-20T13:00:00+00:00","source":"PR Newswire","source_domain":"prnewswire.com","source_url":"https://www.prnewswire.com","summary":"Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies PR Newswire Exclusive | Eli Lilly Strikes Deal for Cancer Biotech WSJ Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion CNBC Eli Lilly\u2019s $3.25 billion acquisition of Kelonia Therapeutics caps startup\u2019s tortuous ride statnews.com Eli Lilly to buy Boston's Kelonia for up to $7 billion in cancer push Reuters","title":"Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies - PR Newswire","url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxQM3cwOTRmS3h5WEFRemsxT1JuYjVLVlJlVE1rYUVxMVpEQlZSWVRaeFBwTnRmMHB3ZnN0SHpFQ0M4QlYyaWJWTTV4ZGZUSndxQi1RYU0tUEZ4YmpoLU5oWEZLSlVoUUZtRTQydnFiSVpTblR5a1VaYUpUOVdtZ1BybEZRSjVhYUhvNmFLZkR2RllhUXdsV0QwdnhLcmpjaWV4Qk9JV2tzVk05MVpVaDM1cWdmNmdhUlJwck8tc2JnVVRlV0hSVkFFVEFfZk1pdw?oc=5"}}... |